Ramucirumab injection, for intravenous use Initial U.S. Approval: 2014
Ramucirumab is used to treat stomach cancer, colorectal cancer, or non-small cell lung cancer that has spread to other parts of the body, and hepatocellular carcinoma. To know the price in India, Phillipines, Vietnam, Ireland call Rakesh on +91 9910645395 or email us at Verve Biosciences for further details.
Facts of CYRAMZA (ramucirumab) injection Medications?
- Medicine Name: Cyramza
- Generic Name: Ramucirumab
- Pack Size: Injection: 100 mg/10 mL (10 mg/mL) or 500 mg/50 mL (10 mg/mL) solution in a single-dose vial
- Company Name: Eli Lilly and Company India Pvt Ltd
What is Ramucirumab injection Medications?
Ramucirumab (LY3009806, IMC-1121B, trade name Cyramza is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.
On 21 April 2014, the US Food and Drug Administration (FDA) approved ramucirumab as a single-agent treatment for advanced gastric cancer or gastro-esophageal junction (GEJ) adenocarcinoma after prior treatment with fluoropyrimidine- or platinum-containing chemotherapy.
Ramucirumab has also been studied in combination with paclitaxel (a type of chemotherapy) and received additional FDA approval on 5 November 2014 as a treatment for people with advanced gastric cancer or GEJ adenocarcinoma after prior treatment with fluoropyrimidine- or platinum-based chemotherapy.
On 12 December 2014, the FDA approved ramucirumab in combination with docetaxel for treatment of metastatic non-small-cell lung carcinoma (NSCLC) with disease progression during or after first-line platinum-containing chemotherapy.
On 24 April 2015, ramucirumab was approved by FDA for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and fluoropyrimidine.
On 10 May 2019, ramucirumab was approved by FDA as a single agent treatment for hepatocellular carcinoma (HCC) in patients who have an alpha fetoprotein (AFP) of > 400 ng/mL and have been previously treated with sorafenib.
How to order Band Name "Ramucirumab injection" Medicine?
Brand Name "Ramucirumab injection" medication can be imported and made available on "Named Patient Program (NPP)" treatment in Philippines, Vietnam, Ireland and India. Please contact at +91 9910645395 (Mr. Rakesh) or make an enquiry at info@cancermedicinesnetwork to find the cost price to buy "Ramucirumab injection" online and have it delivered where you live. We take guarantee of quality and delivery as per the buyer’s requirements.
News Update: Stomach Cancer
Testimonials
How to buy Ramucirumab injection?
Patient, Physcian, distributor/supplier can buy and import Brand Name "Ramucirumab injection" from Verve Biosciences, if the drug has not been approved or is not available in your country. Make an enquiry and we will help you calculate the total price to buy "Ramucirumab injection" online and have it delivered where you live. From your side, we’ll simply need a prescription from your treating doctor. In some countries we might also need an import license. Our Patient Support team will guide you throughout the process.
Can Verve Biosciences send "Ramucirumab injection" to other destination?
Verve Biosciences facilitates import of anti-cancer medicines Ramucirumab injection, Make an enquiry to find the total cost of Ramucirumab injection in UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
